Pier Paolo Olimpieri

Author

Also Known As

P. P. Olimpieri, P.P. Olimpieri, Pier P. Olimpieri, Pier Paolo Olimpieri, PierPaolo Olimpieri, Pierpaolo Olimpieri, Simone Celant

Publications

831

Citations

H-Index

Concepts

All Affiliations

Italian Medicines Agency Sapienza University of Rome University of Milan University of Trieste Istituti di Ricovero e Cura a Carattere Scientifico

About

Pier Paolo Olimpieri is an author at Italian Medicines Agency specializing in medicine, pharmacotherapy, and logistic analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	203
2	Natural Sciences	2	2	89
3	Public Health	2	2	36
4	Engineering	1	1	23
5	Allergy	1	1	60

Pier Paolo Olimpieri

Publications

759

Citations

H-Index

Page 1

	Year	Citations
Insights on protein thermal stability: a graph representation of molecular interactions Mattia Miotto, Pier Paolo Olimpieri, Lorenzo Di Rienzo, Bioinformatics	2018	101
Prediction of site-specific interactions in antibody-antigen complexes: the proABC method and server Pier Paolo Olimpieri, Anna Chailyan, Anna Tramontano, Bioinformatics	2013	97
PIGSPro: prediction of immunoGlobulin structures v2 Rosalba Lepore, Pier Paolo Olimpieri, Mario Abdel Messih, Nucleic Acids Research Structural BioinformaticsBiomolecular Structure PredictionImmunologyMolecular BiologyProteomics	2017	60
Antibody modeling using the Prediction of ImmunoGlobulin Structure (PIGS) web server Paolo Marcatili, Pier Paolo Olimpieri, Anna Chailyan, Nature Protocols VaccinationImmunoglobulin StructureImmunologyComputational BiologySerologic Testing	2014	58
proABC-2: PRediction of AntiBody contacts v2 and its application to information-driven docking Francesco Ambrosetti, Tobias Hegelund Olsen, Pier Paolo Olimpieri, Bioinformatics	2020	47
Tabhu: tools for antibody humanization Pier Paolo Olimpieri, Paolo Marcatili, Anna Tramontano Bioinformatics	2014	41
Chemosensory adaptations of the mountain fly Drosophila nigrosparsa (Insecta: Diptera) through genomics’ and structural biology’s lenses Francesco Cicconardi, Daniele Di Marino, Pier Paolo Olimpieri, Scientific Reports	2017	39
How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) Massimo Breccia, Pier Paolo Olimpieri, Odoardo Maria Olimpieri, Cancer Medicine	2020	38
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis Alice Nevone, M. E. Girelli, Silvia Mangiacavalli, Leukemia Al AmyloidosisBiochemistryNatural SciencesGlycobiologyMolecular Biology	2022	29
Superposition-free comparison and clustering of antibody binding sites: implications for the prediction of the nature of their antigen Lorenzo Di Rienzo, Edoardo Milanetti, Rosalba Lepore, Scientific Reports	2017	28

Page 1